Aptose Biosciences Inc (APTO)
1.20
+0.01
(+0.84%)
USD |
NASDAQ |
May 03, 16:00
1.21
+0.01
(+0.83%)
After-Hours: 20:00
Aptose Biosciences Market Cap: 18.86M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 18.86M |
| May 02, 2024 | 18.70M |
| May 01, 2024 | 19.02M |
| April 30, 2024 | 18.86M |
| April 29, 2024 | 19.33M |
| April 26, 2024 | 19.18M |
| April 25, 2024 | 18.23M |
| April 24, 2024 | 19.18M |
| April 23, 2024 | 19.33M |
| April 22, 2024 | 19.33M |
| April 19, 2024 | 19.35M |
| April 18, 2024 | 19.96M |
| April 17, 2024 | 19.80M |
| April 16, 2024 | 19.96M |
| April 15, 2024 | 20.43M |
| April 12, 2024 | 21.38M |
| April 11, 2024 | 21.69M |
| April 10, 2024 | 21.69M |
| April 09, 2024 | 22.16M |
| April 08, 2024 | 23.10M |
| April 05, 2024 | 21.69M |
| April 04, 2024 | 22.48M |
| April 03, 2024 | 22.63M |
| April 02, 2024 | 24.83M |
| April 01, 2024 | 25.15M |
| Date | Value |
|---|---|
| March 28, 2024 | 26.09M |
| March 27, 2024 | 23.58M |
| March 26, 2024 | 25.15M |
| March 25, 2024 | 23.72M |
| March 22, 2024 | 24.35M |
| March 21, 2024 | 24.66M |
| March 20, 2024 | 23.87M |
| March 19, 2024 | 23.56M |
| March 18, 2024 | 23.56M |
| March 15, 2024 | 23.87M |
| March 14, 2024 | 21.99M |
| March 13, 2024 | 22.62M |
| March 12, 2024 | 23.56M |
| March 11, 2024 | 24.82M |
| March 08, 2024 | 25.60M |
| March 07, 2024 | 26.39M |
| March 06, 2024 | 26.23M |
| March 05, 2024 | 27.64M |
| March 04, 2024 | 28.43M |
| March 01, 2024 | 29.37M |
| February 29, 2024 | 28.27M |
| February 28, 2024 | 29.06M |
| February 27, 2024 | 29.84M |
| February 26, 2024 | 29.84M |
| February 23, 2024 | 29.21M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
14.97M
Minimum
Jan 23 2024
684.98M
Maximum
Feb 20 2020
207.48M
Average
121.86M
Median
Dec 28 2021
Market Cap Benchmarks
| Acasti Pharma Inc | 27.82M |
| Aurinia Pharmaceuticals Inc | 729.40M |
| Edesa Biotech Inc | 14.69M |
| Lexaria Bioscience Corp | 40.33M |
| Xenon Pharmaceuticals Inc | 3.302B |
Market Cap Related Metrics
| Price | 1.20 |
| Earnings Yield | -643.3% |